Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The importance of antihyperglycaemic agents in treatment of lipid disorders and cardiovascular risk reduction Pharmacological reduction of hyperglycaemia in multifactorial treatment of type 2 diabetes mellitus (in addition to treatment of hypertension and dyslipidaemia, lifestyle modification, antiplatelet therapy, etc.) is essential in prevention and inhibition of the progress of chronic diabetes-related complications (macro- and microvascular) and thus affects life expectancy [125, 256, 257]
There is no single best route for everyone
Acknowledgements Not appicable
The removal of duplicates, title/abstract screening, and full-text screening was conducted using the Rayyan application for systematic reviews ( 2.3 Eligibility and study selection Records were included if they involve: i) patients with a confirmed diagnosis of cancer (any type and any stage)
Daftary A, Adler RS
It counteracted both early and delayed neural damage
